AxCell, Mount Sinai to Study Protein Pathways of Neurodegenerative Disorders | GenomeWeb

NEW YORK, Nov. 15 — AxCell Biosciences announced on Thursday that it had formed a research collaboration with the Mount Sinai School of Medicine in New York to study proteins related to neurodegenerative diseases like muscular dystrophy and Alzheimer's.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.